Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tools for assessing health research partnership outcomes and impacts: a systematic review. | Health Res Policy Syst | 2023 | 36604697 | PubTator, text mining | PubMed |
| Molecular profiling of EBV associated diffuse large B-cell lymphoma. | Leukemia | 2023 | 36604606 | PubTator, text mining | PubMed |
| The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases. | Sci Adv | 2023 | 36598996 | PubTator, text mining | PubMed |
| Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: Anticancer effect on MCF-7 cell line. | Iran J Basic Med Sci | 2023 | 36594058 | PubTator, text mining | PubMed |
| Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies. | Blood | 2023 | 36574622 | PubTator, text mining | PubMed |
| Importance of lactate dehydrogenase (LDH) and monocarboxylate transporters (MCTs) in cancer cells. | Health Sci Rep | 2023 | 36570342 | PubTator, text mining | PubMed |
| Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease. | Blood Adv | 2023 | 36516084 | PubTator, text mining | PubMed |
| Circ_0000052/miR-382-3p axis induces PD-L1 expression and regulates cell proliferation and immune evasion in head and neck squamous cell carcinoma. | J Cell Mol Med | 2023 | 36515567 | PubTator, text mining | PubMed |
| Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. | Life Sci | 2023 | 36493876 | PubTator, text mining | PubMed |
| Death within 9 months in patient with follicular dendritic cell sarcoma of spleen: A case report. | Oncol Lett | 2023 | 36478901 | PubTator, text mining | PubMed |
| HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD. | Blood | 2023 | 36477802 | PubTator, text mining | PubMed |
| Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer. | Matrix Biol | 2023 | 36423735 | PubTator, text mining | PubMed |
| Latent membrane protein 1 and macrophage-derived TNFα synergistically activate and mobilize invadopodia to drive invasion of nasopharyngeal carcinoma. | J Pathol | 2023 | 36420735 | PubTator, text mining | PubMed |
| Rituximab Monotherapy for Grade 2-3 Lymphomatoid Granulomatosis with Central Nervous System Involvement in a Patient Receiving Methotrexate for Rheumatoid Arthritis. | Intern Med | 2023 | 36418093 | PubTator, text mining | PubMed |
| Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36372158 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Epstein-Barr virus and multiple sclerosis. | Nat Rev Microbiol | 2023 | 35931816 | PubTator, text mining | PubMed |
| The contemporary management of cancers of the sinonasal tract in adults. | CA Cancer J Clin | 2023 | 35916666 | PubTator, text mining | PubMed |
| Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes. | Fam Cancer | 2023 | 35856126 | PubTator, text mining | PubMed |
| Oncoviruses and melanomas: A retrospective study and literature review. | J Med Virol | 2023 | 35695214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=21